Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nico Gagelmann"'
Autor:
Marie Robin, Nicolaus Kröger, Gérard Socié, Markus Ditschkowski, Dietrich W. Beelen, Anita Badbaran, Rabia Shahswar, Ioanna Triviai, Michael Heuser, Swann Bredin, Bruno Cassinat, Felicitas Thol, Rashit Bogdanov, Nico Gagelmann
Publikováno v:
Blood. 133:2233-2242
Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current prognostic scoring systems aim to select patients for transplantation. Here, we aimed to develop a prognostic score to determine prognosis after transplantat
Autor:
Nico Gagelmann, Michael Heuser, Christina Rautenberg, Victoria Panagiota, Heiko Becker, Dietrich W. Beelen, Marie Robin, Jürgen Finke, Yong Park, Michael Koldehoff, Friedrich Stölzel, Thomas Luft, Maarten Corsten, Nicolaus Kröger, Uwe Platzbecker, Olivier Nibourel, Rachel B. Salit, Aleksandar Radujkovic, Anita Badbaran, Guido Kobbe, Rashit Bogdanov, Bart L. Scott, Maximilian Christopeit
Publikováno v:
Blood Advances, 5, 1760-1769
Blood Adv
Blood Advances, 5, 6, pp. 1760-1769
Blood Adv
Blood Advances, 5, 6, pp. 1760-1769
The inclusion of mutation status improved risk stratification for newly diagnosed patients with chronic myelomonocytic leukemia (CMML). Stem cell transplantation is a potentially curative treatment option, and patient selection is critical because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce521953c246c17c69bac6ae1486fa0e
https://www.ncbi.nlm.nih.gov/pubmed/33755092
https://www.ncbi.nlm.nih.gov/pubmed/33755092
Autor:
Nicolaus Kröger, Andrea Bacigalupo, Dieter Hoelzer, Francesca Bonifazi, Maija Itälä-Remes, Jaime Sanz, Markéta Marková, Carlos Solano, Ellen Meijer, Jörg Halter, Nico Gagelmann, Alessandro Rambaldi
Publikováno v:
JAMA Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
JAMA Oncol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
JAMA Oncol
Question What are the outcomes of haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy compared with other transplant types in adults with hematologic cancers? Findings In this meta-analysis of 30 studies including 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f495cad2ffbd9f87e2a61630b4511228
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15800
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15800
Publikováno v:
Blood. 134:3113-3113
Background Cellular immunotherapies represent an enormously promising strategy for relapsed/refractory multiple myeloma (RRMM). Chimeric antigen receptor (CAR) T cells targeting B cell maturation antigen (BCMA) have shown impressive results in early-
Autor:
Christine Wolschke, Francis Ayuk, Ute-Marie von Pein, Maximilian Gröger, Axel R. Zander, Nicolaus Kröger, Nico Gagelmann, Max Christopeit, Evgeny Klyuchnikov
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(7)
The major reason for treatment failure after allografting in multiple myeloma (MM) is relapse. Donor lymphocyte infusions (DLIs) are considered a valuable post-transplant strategy mainly for relapsed patients but using them to prevent relapse in MM h
Autor:
Nicolaus Kröger, Nico Gagelmann
Publikováno v:
Advances in Cell and Gene Therapy. 1:e12